
WB analysis of Jurkate cell lysate using GTX85278 SHOC2 antibody in (A) the absence and (B) the presence of blocking peptide. Dilution : 1 microg/ml
SHOC2 antibody
GTX85278
Overview
- SupplierGeneTex
- Product NameSHOC2 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1 - 2 microg/mL. IHC-P: 5 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- Concentration1 mg/ml
- FormulationLiquid
- Gene ID8036
- Target nameSHOC2
- Target descriptionSHOC2 leucine rich repeat scaffold protein
- Target synonymsleucine-rich repeat protein SHOC-2; NSLH1; SIAA0862; SOC2; soc-2 suppressor of clear homolog; SUR8
- Protein IDQ9UQ13
- Protein NameLeucine-rich repeat protein SHOC-2
- Scientific DescriptionSHOC2 protein participates in protein binding / transferase activity in the fibroblast growth factor receptor signaling pathway and Ras protein signal transduction. It is a widely expressed protein composed almost entirely of leucine-rich repeats (LRR), with a lysine-rich sequence at the amino terminus and cytoplasmically localized. SHOC2 acts as a positive modulator of the RAS-MAPK signaling cascade, which is elicited by EGL-15 and LET-23 and mediated by LET-60. SHOC2 together with protein phosphatase 1c (PP1c) forms a highly specific M-Ras effector complex and is essential for activation of the MAPK pathway by growth factors. Furthermore, in tumor cells with Ras gene mutations, inhibition of SHOC2 expression inhibits MAPK, but not PI3K activity. The SHOC2-PP1c holoenzyme provides an attractive therapeutic target for inhibition of the MAPK pathway in cancer. Recent studies show that aberrantly acquired N-myristoylation of SHOC2 causes human disease Noonan-like syndrome with loose anagen hair.
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203